Editorial Commentary
New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: is the era of melting glaciers upcoming?
Abstract
The introduction of new metabolic tracers for positron emission tomography (PET) imaging is changing the landscape in the early biochemical recurrence of prostate cancer after radical prostatectomy (1).
